Literature DB >> 9256072

Human type II arginase: sequence analysis and tissue-specific expression.

S M Morris1, D Bhamidipati, D Kepka-Lenhart.   

Abstract

A full-length cDNA encoding type II arginase was isolated from a human kidney cDNA library and its sequence compared to those of vertebrate type I arginases as well as to arginases of bacteria, fungi and plants. The predicted sequence of human type II arginase is 58% identical to the sequence of human type I arginase but is 71% identical to the sequence of Xenopus type II arginase, suggesting that duplication of the arginase gene occurred before mammals and amphibians diverged. Seven residues known to be essential for activity were found to be conserved in all arginases. Type II arginase mRNA was detected in virtually all human and mouse RNA samples tested whereas type I arginase mRNA was found only in liver. At least five mRNA species hybridizing to type II arginase cDNA were found in the human RNA samples whereas only a single type II arginase mRNA species was found in the mouse. This raises the possibility that the multiple type II arginase mRNAs in humans arise from differential RNA processing or usage of alternative promoters.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256072     DOI: 10.1016/s0378-1119(97)00099-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  61 in total

1.  A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.

Authors:  Janete M Cerutti; Rosana Delcelo; Marcelo João Amadei; Claudia Nakabashi; Rui M B Maciel; Bercedis Peterson; Jennifer Shoemaker; Gregory J Riggins
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Endothelial arginase II responds to pharmacological inhibition by elevation in protein level.

Authors:  Karina Krotova; Jawaharlal M Patel; Edward R Block; Sergey Zharikov
Journal:  Mol Cell Biochem       Date:  2010-06-19       Impact factor: 3.396

Review 3.  Labile Low-Molecular-Mass Metal Complexes in Mitochondria: Trials and Tribulations of a Burgeoning Field.

Authors:  Paul A Lindahl; Michael J Moore
Journal:  Biochemistry       Date:  2016-07-19       Impact factor: 3.162

4.  Construction of a highly efficient Bacillus subtilis 168 whole-cell biocatalyst and its application in the production of L-ornithine.

Authors:  Meizhou Wang; Meijuan Xu; Zhiming Rao; Taowei Yang; Xian Zhang
Journal:  J Ind Microbiol Biotechnol       Date:  2015-08-29       Impact factor: 3.346

5.  Hemolysis-associated pulmonary hypertension in thalassemia.

Authors:  Claudia R Morris; Frans A Kuypers; Gregory J Kato; Lisa Lavrisha; Sandra Larkin; Titi Singer; Elliott P Vichinsky
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

Review 6.  Endothelial arginase: a new target in atherosclerosis.

Authors:  Zhihong Yang; Xiu-Fen Ming
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

7.  Localization and differential expression of arginase II in the kidney of male and female mice.

Authors:  Olivier Levillain; Sandra Balvay; Simone Peyrol
Journal:  Pflugers Arch       Date:  2004-12-23       Impact factor: 3.657

Review 8.  Arginase: a critical regulator of nitric oxide synthesis and vascular function.

Authors:  William Durante; Fruzsina K Johnson; Robert A Johnson
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-09       Impact factor: 2.557

9.  Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy.

Authors:  Hanning You; Ting Gao; Timothy K Cooper; Sidney M Morris; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-03

10.  Long-term dietary restriction up-regulates activity and expression of renal arginase II in aging mice.

Authors:  T Majaw; R Sharma
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.